iShares Genomics Immunology and Healthcare ETF
IDNA
IDNA
66 hedge funds and large institutions have $46.4M invested in iShares Genomics Immunology and Healthcare ETF in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 16 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
43% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 14
Holders
66
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.51M | |
| 2 | +$1.49M | |
| 3 | +$980K | |
| 4 |
Nomura Asset Management
Tokyo,
Japan
|
+$599K |
| 5 |
LRPA
L. Roy Papp & Associates
Phoenix,
Arizona
|
+$428K |
Top Sellers
| 1 | -$2.03M | |
| 2 | -$1.8M | |
| 3 | -$1.35M | |
| 4 |
Goldman Sachs
New York
|
-$1.01M |
| 5 |
Baird Financial Group
Milwaukee,
Wisconsin
|
-$963K |